Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus

BACKGROUND: Clinically meaningful endpoints for respiratory syncytial virus (RSV) treatment trials are lacking for hematopoietic cell transplant (HCT) recipients. We evaluated supplemental oxygen use among HCT recipients with RSV infection. METHODS: Subjects were grouped according to the presence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Waghmare, Alpana, Xie, Hu, Kimball, Louise, Yi, Jessica, Özkök, Sezen, Leisenring, Wendy, Cheng, Guang-Shing, Englund, Janet A, Watkins, Timothy R, Chien, Jason W, Boeckh, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853655/
https://www.ncbi.nlm.nih.gov/pubmed/28961971
http://dx.doi.org/10.1093/infdis/jix390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853655/
https://www.ncbi.nlm.nih.gov/pubmed/28961971
http://dx.doi.org/10.1093/infdis/jix390

Ejemplares similares